Trials / Conditions / Myeloproliferative Neoplasm (MPN)

Myeloproliferative Neoplasm (MPN)

5 registered clinical trials studyying Myeloproliferative Neoplasm (MPN) — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxi NCT06859424	Center for International Blood and Marrow Transplant Research	Phase 2
Completed	Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative NCT05153343	Chengdu Zenitar Biomedical Technology Co., Ltd	Phase 1 / Phase 2
Unknown	Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors NCT05115344	Chengdu Zenitar Biomedical Technology Co., Ltd	Phase 1
Completed	Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patient NCT04243122	Ottawa Hospital Research Institute	Phase 2
Terminated	Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Throm NCT00726232	Incyte Corporation	Phase 2